ProShare Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Buy |
|
|||||
|
2025
Q1 | $1.35M | Sell |
|
|||||
|
2024
Q4 | $1.33M | Buy |
|
|||||
|
2024
Q3 | $959K | Buy |
|
|||||
|
2024
Q2 | $688K | Sell |
|
|||||
|
2024
Q1 | $1.03M | Buy |
|
|||||
|
2023
Q4 | $1.21M | Buy |
|
|||||
|
2023
Q3 | $673K | Buy |
|
|||||
|
2023
Q2 | $435K | Buy |
|
|||||
|
2023
Q1 | $381K | Sell |
|
|||||
|
2022
Q4 | $198K | Buy |
|
|||||
|
2022
Q3 | $239K | Sell |
|
|||||
|
2022
Q2 | $227K | Sell |
|
|||||
|
2022
Q1 | $381K | Sell |
|
|||||
|
2021
Q4 | $778K | Sell |
|
|||||
|
2021
Q3 | $2.27M | Sell |
|
|||||
|
2021
Q2 | $3.34M | Buy |
|
|||||
|
2021
Q1 | $2.83M | Buy |
|
|||||
|
2020
Q4 | $2.49M | Buy |
|
|||||
|
2020
Q3 | $1.07M | Sell |
|
|||||
|
2020
Q2 | $955K | Buy |
|
|||||
|
2020
Q1 | $621K | Sell |
|
|||||
|
2019
Q4 | $1.04M | Buy |
|